Oral Oncology
Volume 46, Issue 3 , Pages 178-184, March 2010

Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma – In vitro and in vivo studies

  • Ling-Chang Shen

      Affiliations

    • Institute of Biotechnology, National Cheng Kung University, Tainan, Taiwan
  • ,
  • Yuk-Kwan Chen

      Affiliations

    • Department of Oral Pathology, Faculty of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Division of Dentistry, Department of Oral Pathology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • Corresponding Author InformationCorresponding authors. Addresses: Department of Oral Pathology, Faculty of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Tel.: +886 6 2757575x65600; fax: +886 6 2766505 (Y.-K. Chen), Institute if Biotechnology, National Cheng Kung University, No. 1, University Raod, 701, Tainan, Taiwan (S.-Y. Shaw).
  • ,
  • Li-Min Lin

      Affiliations

    • Department of Oral Pathology, Faculty of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Division of Dentistry, Department of Oral Pathology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
  • ,
  • Shyh-Yu Shaw

      Affiliations

    • Institute of Biotechnology, National Cheng Kung University, Tainan, Taiwan
    • Corresponding Author InformationCorresponding authors. Addresses: Department of Oral Pathology, Faculty of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Tel.: +886 6 2757575x65600; fax: +886 6 2766505 (Y.-K. Chen), Institute if Biotechnology, National Cheng Kung University, No. 1, University Raod, 701, Tainan, Taiwan (S.-Y. Shaw).

Received 26 October 2009; received in revised form 25 November 2009; accepted 25 November 2009. published online 28 December 2009.

Summary 

Regional lymph node and distant organ metastasis of oral squamous-cell carcinoma (OSCC) has been associated with increased production of matrix metalloproteases (MMPs), and scientific data showed that doxycycline (Dox) could down-regulate the expression of MMPs. The objective of this study was to evaluate the effect of Dox on the expression of MMPs in vitro using the SCC-15 cell line and in vivo SCC-15 xenografted nude mice. SCC-15 cells maintained under distinct culture conditions expressed high levels of pro-MMP-2 and pro-MMP-9; however, as determined by zymography and Western blot analysis, Dox significantly reduced the production of pro-MMP-2 and pro-MMP-9 after 24h of treatment in a dose-dependent manner (2.5–40μg/ml). Dox (10μg/ml) decreased the expression of MMP-9 mRNA but did not alter the level of MMP-2 mRNA after 24h of treatment. In addition, this drug significantly inhibited the invasive and migration activities of SCC-15 cells in vitro (>75% inhibition at 10μg/ml). On the other hand, daily administration of Dox (3mg/mice) restrained tumor growth in SCC-15 xenografted nude mice, with an inhibition rate of 85.6%. Compared with the control group (treated with normal saline), MMP-9 mRNA levels in the fresh tumor tissue decreased upon Dox treatment (P<0.01) while MMP-2 mRNA levels were unchanged. In conclusion, reduced expression of MMP-9 at the transcriptional level and MMP-2 at the post-transcriptional level caused by Dox was found to be associated with decreased invasion of oral SCC in vitro. Moreover, Dox exerted a significant suppressive effect on tumor growth in an in vivo nude mice model. Taken together, these results, to our knowledge, may first imply that Doxycycline has an adjuvant therapeutic effect on OSCC that is associated with inhibition of MMPs expression.

Keywords: Oral squamous-cell carcinoma, Doxycycline, Xenograft, Nude mice, MMP-2, MMP-9, Invasion

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(09)00982-8

doi:10.1016/j.oraloncology.2009.11.013

Oral Oncology
Volume 46, Issue 3 , Pages 178-184, March 2010